United Capital Financial Advisers »

Adagio Therapeutics shares owned by United Capital Financial Advisers

Quarter-by-quarter ownership of Adagio Therapeutics (IVVD) shares owned by United Capital Financial Advisers from 13F filings

Historical chart of United Capital Financial Advisers investment in Adagio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Adagio Therapeutics held by United Capital Financial Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adagio Therapeutics by United Capital Financial Advisers

Quarter filed Position value Share count Share price at filing
2025-09-30 $106k 97k 1.10
2025-06-30 $69k 97k 0.71
2025-03-31 $59k 97k 0.61

More positions owned by United Capital Financial Advisers

Vanguard S&p 500 Etf Exchange Traded Fund (VOO)
Ishares Core S&p 500 Etf Exchange Traded Fund (IVV)
Ishares Core Msci Eafe Etf Exchange Traded Fund (IEFA)
Apple Common Stock (AAPL)
Repligen Corp Common Stock (RGEN)
Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Vanguard Short-term Bond Etf Exchange Traded Fund (BSV)
Vanguard Interm-term Bond Etf Exchange Traded Fund (BIV)
Vanguard Value Etf Exchange Traded Fund (VTV)
Vanguard Growth Etf Exchange Traded Fund (VUG)
Ishares Core Msci Emerging Markets Etf Exchange Traded Fund (IEMG)
Alphabet Inc Class A Common Stock (GOOGL)
Ishares Core Universal Usd Bond Etf Exchange Traded Fund (IUSB)
Ishares Us Treasury Bond Etf Exchange Traded Fund (GOVT)

View all positions for United Capital Financial Advisers

Top funds holding Adagio Therapeutics

Henderson Group
Point72 Asset Management
Maverick Capital
RA Capital Management
Mithril II GP
Driehaus Capital Management
M28 Capital Management
ADAR1 Capital Management
683 Capital Management
Vanguard Group
Redmile Group
Ikarian Capital
Eversept Partners
Millennium Management
Boothbay Fund Management

View all funds holding Adagio Therapeutics